Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

NCT06305299 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Ovary Neoplasm
Ovarian Cancer
Epithelial Ovarian Cancer
Recurrent

Interventions

BIOLOGICAL: iC9-CAR.B7-H3 T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

UNC Lineberger Comprehensive Cancer Center